Claudiu V. Cotta, Ph.D.

Affiliations: 
2004 University of Alabama, Birmingham, Birmingham, AL, United States 
Area:
Pathology, Immunology
Google:
"Claudiu Cotta"

Parents

Sign in to add mentor
Christopher A. Klug grad student 2004 UAB
 (The role of the transcription factors Pax5 and E47 in early lymphopoiesis.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Merzianu M, Groman A, Hutson A, et al. (2018) Trends in Bone Marrow Sampling and Core Biopsy Specimen Adequacy in the United States and Canada: A Multicenter Study. American Journal of Clinical Pathology
Kim HG, LeGrand J, Swindle CS, et al. (2017) The assembly competence domain is essential for inv(16)-associated acute myeloid leukemia. Leukemia
Vatolin S, Phillips JG, Jha BK, et al. (2016) Novel protein disulfide isomerase inhibitor with anti-cancer activity in multiple myeloma. Cancer Research
Arrossi AV, Merzianu M, Farver C, et al. (2015) Nodular pulmonary light chain deposition disease: an entity associated with Sjögren syndrome or marginal zone lymphoma. Journal of Clinical Pathology
Ruiz SJ, Cotta CV. (2015) Follicular helper T-cell lymphoma: A B-cell-rich variant of T-cell lymphoma Annals of Diagnostic Pathology. 19: 187-192
Nakashima MO, Shetty S, Chicka M, et al. (2015) Transient abnormal myelopoiesis of a newborn not associated with chromosome 21 abnormalities or GATA1 mutations Pediatric Blood and Cancer. 62: 353-355
Park IJ, Bena J, Cotta CV, et al. (2014) Frequency, interobserver reproducibility and clinical significance of equivocal peaks in PCR clonality testing using Euroclonality/BIOMED-2 primers. Journal of Clinical Pathology. 67: 1093-8
Cotta CV, Hsi ED. (2014) IgG4+ plasma cells in isolated reactive lymphadenopathy. American Journal of Clinical Pathology. 142: 432-4
Turakhia SK, Hill BT, Dufresne SD, et al. (2014) Aggressive B-cell lymphomas with translocations involving BCL6 and MYC have distinct clinical-pathologic characteristics. American Journal of Clinical Pathology. 142: 339-46
Theil KS, Cotta CV. (2014) The prognostic significance of an inv(3)(q21q26.2) in addition to a t(9;22)(q34;q11.2) in patients treated with tyrosine kinase inhibitors. Cancer Genetics. 207: 171-6
See more...